The Mucosal Incision Knife segmentation by application delineates three primary procedural clusters that collectively drive market volume. Endoscopic Submucosal Dissection (ESD) accounts for the largest share, reflecting its widespread adoption for en bloc resection of early gastrointestinal neoplasms; the knife’s precision and controllable depth of incision are critical for achieving clear margins, thereby sustaining high unit demand. Peroral Endoscopic Myotomy (POEM) represents a rapidly expanding niche, where the instrument’s ability to create longitudinal muscle incisions under minimal trauma supports its growing use in achalasia treatment, contributing a substantial secondary portion of sales. The residual category, Other Gastrointestinal Procedures, aggregates applications such as gastric bypass revisions, Barrett's esophagus ablation, and experimental endoscopic therapies; although individually modest, their aggregate impact is non‑trivial and provides diversification against procedural volatility. These application segments translate directly into revenue streams, with each proportionally influencing production planning, R&D allocation, and regional market penetration strategies.